ICCC NASDAQ
ImmuCell Corporation
1W: -1.8%
1M: -2.5%
3M: -3.1%
YTD: +64.7%
1Y: +47.7%
3Y: +80.6%
5Y: -0.1%
$9.75
+0.15 (+1.56%)
Weekly Expected Move ±3.1%
$9
$9
$10
$10
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-11-16
Earliest Filing
2024-12-02
Latest Filing
partner: 4
supplier: 2
Counterparties (Filed by ICCC)
6 relationshipsCompanies named in ICCC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Norbrook Laboratories Limited | — | supplier | Amendment to Development Services and Commercial Supply Agreement for formulation, aseptic filling, and packaging servic | 2024-12-02 | View |
| TVP, LLC | — | partner | Landlord entering into a Fifth Amendment of Lease with ImmuCell Corporation. | 2024-09-24 | View |
| TVP, LLC | — | partner | Entered into a Fourth Amendment of Lease regarding Portland, Maine premises. | 2024-06-14 | View |
| Craig-Hallum Capital Group LLC | — | partner | Sales Agent for At The Market Offering Agreement | 2024-04-09 | View |
| Norbrook Laboratories Limited | — | supplier | Amendment to Development Services and Commercial Supply Agreement for formulation, aseptic filling, and packaging servic | 2024-03-06 | View |
| TVP, LLC | — | partner | Landlord entering a lease amendment with the Company | 2023-11-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-07-09 | Earnings Release; Exhibits | View | |
| 2026-06-17 | Shareholder Vote; Exhibits | View | |
| 2026-06-10 | Regulation FD; Exhibits | View | |
| 2026-05-08 | Material Agreement | Agreement | View |
| 2026-04-14 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-04-08 | Earnings Release; Exhibits | View | |
| 2026-03-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-02-02 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2026-01-08 | Results of Operations and Financial Condition; Material Impairments; Other Events; Financial Stateme | View | |
| 2025-12-29 | Material Impairments; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-04 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-10-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-30 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2025-08-25 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-07-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR